FindTrial
Sign In

Presentation of patients with Tb lymph node and their response on therapy

Clinical profile and response to treatment of patients with peripheral Tubercular Lymphadenitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058874
Enrollment
40
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A182- Tuberculous peripheral lymphadenopathy

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are newly diagnosed with Tubercular Lymphadenitis on FNAC/Biopsy. Patients ready to give written informed consent.

Exclusion criteria

Exclusion criteria: Patients who are already on Anti Tubercular Therapy.

Design outcomes

Primary

MeasureTime frame
To study the clinical characteristics & presentation of patients with peripheral Tubercular LymphadenitisTimepoint: 2 months—

Secondary

MeasureTime frame
To study the presence of mycobacterium on ZN staining. To study the response to treatment at the end of 2 monthsTimepoint: 2 months—

Countries

India

Contacts

Public ContactGrisha Maich

Maulana Azad Medical College

drnareshmamc@gmail.com9953946064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026